Stryker Corporation (SYK) exhibits 64.0% gross margins and 11.6% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 23.6x enterprise multiple and 7.3% implied options volatility.
Sustained 64.0% gross profitability converts into 19.5% operating margin and 11.6% ROIC, outpacing sector cost of capital.
ROIC: 11.6% // GM: 64.0%YoY revenue trajectory of +11.2% paired with 3.58% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +11.2% // FCF YLD: 3.58%Altman Z-Score of 4.46 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 4.46 // F-SCORE: 9/9Trading at 36.8x trailing P/E (34.2x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 36.8x // EV/EBITDA: 23.6xOptions market prices a ±7.3% implied move with a 0.74 put/call ratio around $306.00 max pain.
IMPL MOVE: ±7.3% // P/C: 0.74Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 12.9% net margins.
NET MARGIN: 12.9% // D/E: 0.66x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for SYK & activate live FRED threshold breach alerts.